Results 51 to 60 of about 4,987,259 (403)
Experimental Nuclear Medicine Meets Tumor Biology
Pharmaceuticals, 2022 Personalized treatment of cancer patients demands specific and validated biomarkers for tumor diagnosis and therapy. The development and validation of such require translational preclinical models that recapitulate human diseases as accurately as ...
Theresa Balber +5 more
doaj +1 more source
Compartmental analysis of dynamic nuclear medicine data: models and identifiability [PDF]
, 2016 Compartmental models based on tracer mass balance are extensively used in clinical and pre-clinical nuclear medicine in order to obtain quantitative information on tracer metabolism in the biological tissue.
Delbary, Fabrice +2 more
core +2 more sources
Theranosticsin nuclear medicine and oncology
Atti della Accademia Peloritana dei Pericolanti - Classe di Scienze Medico-Biologiche, 2019 Nowadays, the incidence of tumors is constantly growing, affecting older patients who are frequently exhibiting comorbidities. The occurrence of side effects may represent a problem for treatment compliance of patients. In order to manage this challenge,
Sergio Baldari +2 more
doaj +1 more source
Applications of neutron activation spectroscopy [PDF]
, 2013 Since the discovery in 1932, neutrons became a basis of many methods used not only in research, but also in industry and engineering. Among others, the exceptional role in the modern nuclear engineering is played by the neutron activation spectroscopy ...
Silarski, M.
core +2 more sources
History and Perspectives of Nuclear Medicine in Bangladesh [PDF]
Asia Oceania Journal of Nuclear Medicine and Biology, 2016 Bangladesh is one of the smaller states in Asia. But it has a long and rich history of nuclear medicine for over sixty years. The progress in science and technology is always challenging in a developing country.
Raihan Hussain
doaj +1 more source
The Future of Nuclear Medicine, Molecular Imaging, and Theranostics.
Journal of Nuclear Medicine, 2020 ### Wolfgang A. Weber and Johannes Czernin Scientific discoveries published in The Journal of Nuclear Medicine over the past 60 years have shaped the practice of medicine and form the foundation for the future of nuclear medicine, molecular imaging, and
W. Weber +21 more
semanticscholar +1 more source
European Journal of Nuclear Medicine and Molecular Imaging, 2020 The EC Directive 2013/59/Euratom states in article 56 that exposures of target volumes in nuclear medicine treatments shall be individually planned and their delivery appropriately verified. The Directive also mentions that medical physics experts should
M. Konijnenberg +6 more
semanticscholar +1 more source
Is nuclear medicine really safe?
Brazilian Archives of Biology and Technology, 2002 In nuclear medicine, radiation absorbed dose estimates calculated by standard models at the whole body or organ are very low. At cellular level, however, the heterogeneity of radionuclide distributions of radiation dose patterns may be significant.
Nicole Colas-Linhart
doaj +1 more source
European Journal of Nuclear Medicine and Molecular Imaging, 2021 The world is amidst a COVID-19 pandemic. It started in December 2019, when a new type of coronavirus 2019nCoV/SARS-CoV-2, causing the COVID-19 disease, was extracted and identified from the patient’s lower respiratory tract samples in Wuhan, China [1 ...
G. Gnanasegaran +9 more
semanticscholar +1 more source
FoxO1 signaling in B cell malignancies and its therapeutic targeting
FEBS Letters, EarlyView.FoxO1 has context‐specific tumor suppressor or oncogenic character in myeloid and B cell malignancies. This includes tumor‐promoting properties such as stemness maintenance and DNA damage tolerance in acute leukemias, or regulation of cell proliferation and survival, or migration in mature B cell malignancies.
Krystof Hlavac +3 more
wiley +1 more source